{"id":"https://openalex.org/W122681985","doi":"https://doi.org/10.1007/978-3-322-90784-4_11","title":"Verbraucherorganisationen, Patienten- und B\u00fcrgerinitiativen \u2014 Politischer Umgang mit neuen Kr\u00e4ften","display_name":"Verbraucherorganisationen, Patienten- und B\u00fcrgerinitiativen \u2014 Politischer Umgang mit neuen Kr\u00e4ften","publication_year":1995,"publication_date":"1995-01-01","ids":{"openalex":"https://openalex.org/W122681985","doi":"https://doi.org/10.1007/978-3-322-90784-4_11","mag":"122681985"},"language":"de","primary_location":{"id":"doi:10.1007/978-3-322-90784-4_11","doi":"https://doi.org/10.1007/978-3-322-90784-4_11","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-3-322-90784-4_11","pdf_url":null,"source":{"id":"https://openalex.org/S4306463308","display_name":"Gabler Verlag eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Handbuch Pharma-Management","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W2498647187","display_name":"Handbuch Pharma-Management"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085791900","display_name":"E G Afting","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ernst-G\u00fcnter Afting","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055692445","display_name":"R. G. Geursen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Geursen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.06193353,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"245","last_page":"253"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11121","display_name":"Public Relations and Crisis Communication","score":0.41819998621940613,"subfield":{"id":"https://openalex.org/subfields/3315","display_name":"Communication"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11121","display_name":"Public Relations and Crisis Communication","score":0.41819998621940613,"subfield":{"id":"https://openalex.org/subfields/3315","display_name":"Communication"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12225","display_name":"Political Influence and Corporate Strategies","score":0.3109999895095825,"subfield":{"id":"https://openalex.org/subfields/1408","display_name":"Strategy and Management"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.07919999957084656,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/consumer-associations","display_name":"consumer associations","score":0.878000020980835},{"id":"https://openalex.org/keywords/patient-associations","display_name":"patient associations","score":0.6890000104904175},{"id":"https://openalex.org/keywords/citizen-initiatives","display_name":"citizen initiatives","score":0.8759999871253967},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.8820000290870667},{"id":"https://openalex.org/keywords/public-acceptance","display_name":"public acceptance","score":0.7739999890327454},{"id":"https://openalex.org/keywords/public-relations","display_name":"public relations","score":0.49300000071525574},{"id":"https://openalex.org/keywords/corporate-image","display_name":"corporate image","score":0.41999998688697815},{"id":"https://openalex.org/keywords/corporate-social-responsibility","display_name":"corporate social responsibility","score":0.48100000619888306},{"id":"https://openalex.org/keywords/stakeholder-relationships","display_name":"stakeholder relations","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C15708023","wikidata":"https://www.wikidata.org/wiki/Q80083","display_name":"Humanities","level":1,"score":0.6537041664123535},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.5947436690330505},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.36103227734565735}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-3-322-90784-4_11","doi":"https://doi.org/10.1007/978-3-322-90784-4_11","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-3-322-90784-4_11","pdf_url":null,"source":{"id":"https://openalex.org/S4306463308","display_name":"Gabler Verlag eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Handbuch Pharma-Management","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1828691400","https://openalex.org/W2794595934","https://openalex.org/W116492383","https://openalex.org/W7039496991","https://openalex.org/W4236497388","https://openalex.org/W2057839907","https://openalex.org/W106297855","https://openalex.org/W63397982","https://openalex.org/W1033231803","https://openalex.org/W4231231189"],"abstract_inverted_index":{"Die":[0],"Frage":[1],"der":[2,28,31,79,104,118,127,135],"gesellschaftlichen":[3,139],"Akzeptanz":[4],"wird":[5],"in":[6,70,167],"unserer":[7],"Gesellschaft":[8],"von":[9,62,76,154],"immer":[10],"gr\u00f6\u00dferer":[11],"Bedeutung,":[12],"insbesondere":[13],"wenn":[14,92],"man":[15],"die":[16,51,57,83,151,165],"Wettbewerbsf\u00e4higkeit":[17],"des":[18],"Unternehmens":[19],"erhalten":[20],"will.":[21],"Andererseits":[22],"gibt":[23],"es":[24,123],"zahlreiche":[25],"Konfliktfelder":[26],"zwischen":[27],"\u00d6ffentlichkeit":[29,136],"und":[30,49,64,73,89,129,150],"Pharmabranche.":[32],"Unter":[33],"diesen":[34,147],"Aspekt":[35],"finden":[36],"Kritiker":[37],"vieles,":[38],"was":[39,100],"ihre":[40],"Verdachtsmomente":[41],"best\u00e4tigt.":[42],"Moralische":[43],"Entr\u00fcstung":[44],"dient":[45],"dann":[46],"als":[47],"St\u00fctze":[48],"erleichtert":[50],"permanente":[52],"Suche":[53],"nach":[54],"S\u00fcndenb\u00f6cken.":[55],"Unternehmen,":[56],"sich":[58,68,86,94],"mit":[59,95,134,146,159],"t\u00e4glichen":[60],"Abw\u00e4gungen":[61],"Gewinn":[63],"Verlust":[65],"besch\u00e4ftigen,":[66],"unterscheiden":[67],"grunds\u00e4tzlich":[69],"ihrem":[71,74],"Selbstbild":[72],"Zeithorizont":[75],"den":[77,101,161,168],"Ansichten":[78],"\u00d6ffentlichkeit.":[80],"Dar\u00fcberhinaus":[81],"neigt":[82],"Pharmabranche":[84],"dazu,":[85],"zu":[87,90,142,156,160],"rechtfertigen":[88],"verteidigen,":[91],"sie":[93],"\u00f6ffentlichen":[96],"Problemen":[97],"konfrontiert":[98],"sieht,":[99],"bestehenden":[102],"Verdacht":[103],"Menschen":[105],"eher":[106],"noch":[107],"best\u00e4rkt.":[108],"\u201eNicht":[109],"Tatsachen,":[110],"sondern":[111],"Meinungen":[112],"\u00fcber":[113],"Tatsachen":[114],"bestimmen":[115],"das":[116],"Verhalten":[117],"Menschen\u201c":[119],"(Epictetus).":[120],"Folglich":[121],"bedarf":[122],"einer":[124],"fortdauernden":[125],"Analyse":[126],"Firmenaktivit\u00e4ten":[128],"Produkte,":[130],"um":[131],"m\u00f6gliche":[132],"Konflikte":[133],"oder":[137],"bestimmten":[138],"Gruppen":[140],"fr\u00fchzeitig":[141],"erkennen.":[143],"Der":[144],"Umgang":[145],"neuen":[148],"Kr\u00e4ften":[149],"Absicht,":[152],"auch":[153],"ihnen":[155],"lernen,":[157],"geh\u00f6rt":[158],"gr\u00f6\u00dften":[162],"Herausforderungen":[163],"f\u00fcr":[164],"Pharmaindustrie":[166],"vor":[169],"uns":[170],"liegenden":[171],"Jahren.":[172]},"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}